Log in to search using one of your social media accounts:

 

Apixaban -- metabolism, pharmacologic properties and drug interactions
(Bentham Science Publishers) New oral anticoagulants (NOACs) represent direct-acting drugs functioning selectively for one specific clotting factor. Their clinical indications are the prophylaxis and treatment of deep venous thrombosis and pulmonary embolism, the prevention of atherothrombotic episodes of individuals with acute coronary syndromes and atrial fibrillation (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 20, 2017 Category: International Medicine & Public Health Source Type: news

Editor's highlight: pulmonary vascular thrombosis in rats exposed to inhaled sulfur mustard - McGraw MD, Osborne CM, Mastej EJ, Di Paola JA, Anderson DR, Holmes WW, Paradiso DC, Garlick RB, Hendry-Hofer TB, Rancourt RC, Smith RW, Burns C, Roe GB, Rioux JS, White CW, Veress LA.
Sulfur mustard (SM) is a chemical warfare agent. When inhaled, SM causes significant injury to the respiratory tract. Although the mechanism involved in acute airway injury after SM inhalation has been well described previously, the mechanism of SM's contr... (Source: SafetyLit)
Source: SafetyLit - October 4, 2017 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Your NEJM Group Today: Thrombophilia Testing Review Article / Self-Grooming Disorders / California Pulmonary & Sleep Opportunities (FREE)
By the Editors Here's what we chose for you from NEJM Group today:NEJM Clinical Practice Center: Review Article: Most patients with venous thromboembolism do not … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 26, 2017 Category: Primary Care Source Type: news

DVT (Deep Vein Thrombosis) and Pulmonary Embolism (PE) Quiz
Title: DVT (Deep Vein Thrombosis) and Pulmonary Embolism (PE) QuizCategory: MedicineNet QuizCreated: 7/31/2014 12:00:00 AMLast Editorial Review: 9/20/2017 1:12:43 PM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - September 20, 2017 Category: Cardiology Source Type: news

Studies support anti-stroke PFO closure devices from Abbott, Gore
Sykes and Clark; licensee BioMed Central Ltd. A trio of studies published this week in the New England Journal of Medicine showed that devices from Abbott (NYSE:ABT) and W.L. Gore & Assoc. designed to close a heart defect lowered the risk of a recurring episode in certain cryptogenic stroke patients. Long-term results from the 980-patient Respect trial of the Amplatzer device Abbott acquired along with St. Jude Medical this year, along with data from the Reduce study of Gore’s Helex and Cardioform and the French Close study of PFO closure devices with CE Mark approval, showed that they reduced the risk of re...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Clinical Trials Surgical Abbott Structural heart W.L. Gore & Associates Source Type: news

Diving accident-induced arterial gas embolism - Nijk PD, van Rees Vellinga TP, van Lieshout JM, Gaakeer MI.
BACKGROUND: During scuba diving, nitrogen dissolves into the body tissues due to elevated pressure under water. During a sudden drop in pressure due to a rapid return to the water surface, arterial gas embolism can arise from pulmonary barotrauma. In a lat... (Source: SafetyLit)
Source: SafetyLit - September 9, 2017 Category: International Medicine & Public Health Tags: Drowning, Suffocation Source Type: news

For post-menopausal women, vaginal estrogens do not raise risk of cancer, other diseases
This study, the first to examine potential adverse health effects in users of vaginal estrogen compared with non-users, suggests that vaginal estrogen therapy is a safe treatment for genitourinary symptoms such as burning, discomfort, and pain during intercourse associated with menopause.AUTHORSThe paper ’s authors are Dr. Carolyn Crandall of UCLA; Kathleen Hovey of the State University of New York at Buffalo; Christopher Andrews of the University of Michigan; Dr. Rowan Chlebowski of City of Hope; Marcia Stefanick of Stanford University; Dr. Dorothy Lane of the State University of New York at Ston y Brook; Dr. Jan Sh...
Source: UCLA Newsroom: Health Sciences - August 16, 2017 Category: Universities & Medical Training Source Type: news

In assessing risk of hormone therapy for menopause, dose — not form — matters
FINDINGSWhen it comes to assessing the risk of estrogen therapy for menopause, how the therapy is delivered — taking a pill versus wearing a patch on one’s skin — doesn’t affect risk or benefit, researchers at UCLA and elsewhere have found. But with the commonly used conjugated equine estrogen, plus progestogen, the dosage does. Higher doses, especially over time, are associated with greater risk of problems, including heart disease and some types of cancer, especially among obese women.BACKGROUNDThe Women ’s Health Initiative established the potential of estrogen therapy to increase or decrea...
Source: UCLA Newsroom: Health Sciences - July 27, 2017 Category: Universities & Medical Training Source Type: news

Risk factors for deep vein thrombosis and pulmonary embolism after traumatic injury: a competing risks analysis - Van Gent JM, Calvo RY, Zander AL, Olson EJ, Sise CB, Sise MJ, Shackford SR.
BACKGROUND: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is typically reported as a composite measure of the quality of trauma center care. Given recent data suggesting post-injury DVT and PE are distinct ... (Source: SafetyLit)
Source: SafetyLit - July 15, 2017 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Prevalence of Pulmonary Embolism Among SLE Discharges Prevalence of Pulmonary Embolism Among SLE Discharges
This study takes a closer look.Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 14, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Novel PET tracer detects small blood clots
(Society of Nuclear Medicine) Blood clots in veins and arteries can lead to heart attack, stroke, and pulmonary embolism, which are major causes of mortality. In the featured article of The Journal of Nuclear Medicine's July 2017 issue, German researchers show that targeting GPIIb/IIIa receptors, the key receptor involved in platelet clumping, with a fluorine-18 labeled ligand is a promising approach for diagnostic imaging. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 6, 2017 Category: International Medicine & Public Health Source Type: news

Managing Intra-operative Acute PE During General Anesthesia Managing Intra-operative Acute PE During General Anesthesia
Pulmonary embolism occurring during surgery is a rare and serious complication, and difficult to diagnose under anesthesia. How was it detected in this patient?BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2017 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Bio2 touts pivotal data on Angel catheter-filter combo
This study of a combined IVC filter/central venous catheter was the culmination of a panel of dedicated investigators with careful guidance by the FDA,” primary investigator Dr. Victor Tapson said in prepared remarks. “The efficacy and safety of the device, simple bedside placement, and the need to remove it before discharge make it very appealing. Nearly the entire cohort had crucial, yet short-term filter needs so that discharge without a filter was preferred.” The device is the 1st to be cleared by the FDA for PE prophylaxis in critically ill patients contraindicated to anticoagulation. “The publ...
Source: Mass Device - June 30, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Catheters Clinical Trials Vascular BiO2 Medical Source Type: news

Portola shares soar after FDA approves clot preventing drug
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved a new oral blood-thinner made by Portola Pharmaceuticals Inc to prevent deep vein thrombosis and pulmonary embolisms in acutely ill patients who are not undergoing surgery. (Source: Reuters: Health)
Source: Reuters: Health - June 23, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA approves Portola blood-thinner to prevent clots
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved a new oral blood-thinner made by Portola Pharmaceuticals Inc to prevent deep vein thrombosis and pulmonary embolisms in acutely ill patients who are not undergoing surgery. (Source: Reuters: Health)
Source: Reuters: Health - June 23, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. FDA approves Portola blood-thinner to prevent clots
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved a new oral blood-thinner made by Portola Pharmaceuticals Inc to prevent deep vein thrombosis and pulmonary embolisms in acutely ill patients who are not undergoing surgery. (Source: Reuters: Health)
Source: Reuters: Health - June 23, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. FDA approves Portola blood-thinner to prevent blood clots
(Reuters) - The U.S. Food and Drug Administration on Friday approved a new oral blood-thinner made by Portola Pharmaceuticals Inc to prevent deep vein thrombosis and pulmonary embolisms in acutely ill patients who are not undergoing surgery. (Source: Reuters: Health)
Source: Reuters: Health - June 23, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

MassDevice.com +5 | The top 5 medtech stories for June 5, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. SentreHeart enters pivotal phase after hitting Lariat study milestone SentreHeart can launch the 2nd, pivotal phase in the Amaze study of its Lariat device, after hitting the mark in the 1st, 100-patient stage. Like the Watchma...
Source: Mass Device - June 5, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

SentreHeart enters pivotal phase after hitting Lariat study milestone
SentreHeart can launch the 2nd, pivotal phase in the Amaze study of its Lariat device, after hitting the mark in the 1st, 100-patient stage. Like the Watchman anti-stroke device made by Boston Scientific (NYSE:BSX), Lariat is designed to occlude the left atrial appendage, but unlike Watchman it’s intended to help treat atrial fibrillation alongside pulmonary vein isolation. The FDA approved an expansion of the study, which can now enroll another 500 patients after an independent data monitoring committee reviewed the data against preset safety and performance criteria, Redwood City, Calif.-based S...
Source: Mass Device - June 5, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Clinical Trials Food & Drug Administration (FDA) Cardiac Rhythm Management SentreHeart Source Type: news

New guidelines for in-flight emergencies, proposed
All planes should carry defibrillators, say experts Related items fromOnMedica Fainting after air travel could be a sign of pulmonary embolism European advice launched on heart failure Safety questions over adrenaline for cardiac arrest CPR training drive for public to focus on youth (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 5, 2017 Category: UK Health Source Type: news

Medtronic recalls Kyphon bone cement
Medtronic (NYSE:MDT) is recalling some of its Kyphon bone cement after discovering a misalignment issue with the instrument that delivers the cement. The Fridley, Minn.-based company sent a letter to customers last month detailing the issue with the Kyphon directional bone filler, saying it received 2 reports that “the directional arrow at the proximal end of the instrument may not correctly align with the cut‐out opening on the distal end of the instrument.” That means the cement could be injected in “a direction unintended by the surgeon,” Medtronic said in the letter. The problem hasn&rsqu...
Source: Mass Device - June 1, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Orthopedics Recalls Spinal Medtronic Source Type: news

UPDATE: Medtronic recalls Kyphon bone cement device
This article originally and incorrectly stated that Medtronic is recalling the Kyphon bone cement, not the filler instrument that is being recalled. ↩ The post UPDATE: Medtronic recalls Kyphon bone cement device appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - June 1, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Orthopedics Recalls Spinal Medtronic Source Type: news

BTG's PE Device Works Faster and at Lower Doses in Study BTG's PE Device Works Faster and at Lower Doses in Study
British pharmaceutical firm BTG said its EKOS combination therapy device for pulmonary embolism (PE) was effective using smaller drug dosages and shorter treatment periods than the current standard.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - May 30, 2017 Category: Intensive Care Tags: Pulmonary Medicine News Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 25, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Artificial pancreas: These companies are racing to make one Medical device companies are close to achieving the holy grail of diabetes treatment: a combined glucose sensor, control algorithm and insulin infusion device that eff...
Source: Mass Device - May 25, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Ultrasound-drug combo treats pulmonary embolism in less time with fewer drugs
When venous clots break off and travel through a patient’s circulatory system, they can become trapped in the lung and block blood flow. This strains the heart’s ability to pump blood through the lungs and can ultimately lead to heart failure. Traditionally, patients with pulmonary embolisms are treated overnight with systemic infusions of tissue plasminogen activator. But, according to Dr. Victor Tapson at Cedars-Sinai Medical Center in Los Angeles, large doses of tPA are associated with side effects including intracranial bleeding and smaller doses can be safer and just as effective as the larger, c...
Source: Mass Device - May 25, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Vascular Wall Street Beat BTG Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 22, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. BoneSupport launches trial of antibiotic-eluting bone graft BoneSupport said today that the 1st patient has been enrolled in the pivotal investigational device exemption trial for its injectable antibiotic-eluting bone graft su...
Source: Mass Device - May 22, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

BTG touts Ekos data from pulmonary embolism trial
BTG (LON:BTG) touted data today from the Optalyse PE trial showing that pulmonary embolism can be treated effectively with Ekos over a shorter period and with smaller doses of thrombolytic drugs compared to the current standard. The 101-patient trial randomized participants to receive therapeutic anticoagulation and Ekos acoustic pulse thrombolysis therapy at different doses for different lengths of time. The 1st group received 4 milligrams per catheter of tissue plasminogen activator over 2 hours, while the 2nd cohort received the same dose over 4 hours. The 3rd group was treated with 6 milligrams per catheter o...
Source: Mass Device - May 22, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Clinical Trials Drug-Device Combinations Wall Street Beat BTG Source Type: news

BTG's pulmonary embolism device work faster and at lower doses in study
LONDON (Reuters) - British pharmaceutical firm BTG said on Monday its EKOS combination therapy device for pulmonary embolism (PE) was effective using smaller drug dosages and shorter treatment periods than the current standard. (Source: Reuters: Health)
Source: Reuters: Health - May 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Perioperative Aspirin for Venous Thromboembolism Prevention Perioperative Aspirin for Venous Thromboembolism Prevention
This study investigated whether perioperative aspirin is effective in the prevention of post-surgical venous thromboembolism, including deep vein thrombosis and pulmonary embolism.Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 22, 2017 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Pulmonary embolism following severe traumatic brain injury: incidence, risk factors and impact outcome - Bahloul M, Chelly H, Regaieg K, Rekik N, Bellil S, Chaari A, Bouaziz W, Chabchoub I, Haddar S, Hamida CB, Bouaziz M.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - May 19, 2017 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

IVC Filters Still a Question Mark for Prevention in Trauma (CME/CE)
(MedPage Today) -- Trends in use don't match up with pulmonary embolism rates (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - May 10, 2017 Category: Respiratory Medicine Source Type: news

SNMMI publishes appropriate use criteria for V/Q imaging in pulmonary embolism
(Society of Nuclear Medicine) The Society of Nuclear Medicine and Molecular Imaging has published appropriate use criteria for ventilation/perfusion (V/Q) imaging in pulmonary embolism. This is the second in a series of new AUC developed by SNMMI in its role as a qualified provider-led entity under the Medicare Appropriate Use Criteria program for advanced diagnostic imaging. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 1, 2017 Category: Global & Universal Source Type: news

Bypassing Clinical Decision Support Tools for Imaging in the ED Bypassing Clinical Decision Support Tools for Imaging in the ED
What happens when emergency department providers ignore CDS alerts and send suspected pulmonary embolism cases straight to the scanner?Medscape Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 20, 2017 Category: Consumer Health News Tags: Radiology Viewpoint Source Type: news

Inari Medical wins FDA nod for ClotTriever peripheral thrombectomy device
Inari Medical said today that the FDA granted pre-market approval in February for its ClotTriever thrombectomy device Feb. 16 and already has the 1st commercial procedure under its belt. Irvine, Calif.-based Inari said the ClotTriever device is designed to remove blood clots from large vessels in the peripheral vasculature. The company also makes the FlowTriever device, which is designed to retrieve pulmonary embolisms. “The ClotTriever system is the 2nd product offering in Inari’s product portfolio,” CEO Bill Hoffman said in prepared remarks.  “The ClotTriever is curre...
Source: Mass Device - April 10, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Regulatory/Compliance Wall Street Beat Inari Medical Peripheral Artery Disease Source Type: news

Role of imaging modalities is changing for PE diagnosis
The use of ventilation/perfusion SPECT scans to rule out pulmonary embolism...Read more on AuntMinnie.comRelated Reading: Video from ECR 2017: Dr. Martine Rémy-Jardin on pulmonary embolism Ultrasound elevates diagnosis of pulmonary embolism Triple rule-out CT offers one-stop shop for chest pain Can ultrasound for deep vein thrombosis cause a PE? Societies issue imaging guidelines for chest pain (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 31, 2017 Category: Radiology Source Type: news

No Increased Risks for DOAC Use Versus Warfarin in VTE
Direct oral anticoagulants not linked to increased risk of major bleeding, death in venous thromboembolism (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - March 28, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Internal Medicine, Critical Care, Emergency Medicine, Neurology, Nursing, Pathology, Pharmacy, Pulmonology, Journal, Source Type: news

Tomographic imaging advances considered good yet can lead to overdiagnosis in PE patients
(American Roentgen Ray Society) Although advances in tomographic imaging have improved the sensitivity of ventilation-perfusion (V/Q) scans for pulmonary embolism (PE), they may lead to overdiagnosis by revealing small and clinically insignificant PEs, according to a state-of-the-art review published in the March 2017 issue of the American Journal of Roentgenology (AJR). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 28, 2017 Category: Global & Universal Source Type: news

Long - Term Thrombolytic Tx No Benefit in Intermediate - Risk PE
Findings at three years for tenecteplase vs placebo in patients with intermediate - risk pulmonary embolism (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - March 27, 2017 Category: Respiratory Medicine Tags: Cardiology, Oncology, Pharmacy, Pulmonology, Journal, Source Type: news

Bayer's Rivaroxaban demonstrated superior protection against recurrent venous thromboembolism compared with Aspirin in EINSTEIN CHOICE study
Bayer AG and its development partner Janssen Pharmaceuticals, Inc. have announced results from the EINSTEIN CHOICE study, which demonstrated that both 10 mg and 20 mg once-daily dosages of its oral Factor Xa inhibitor rivaroxaban (Xarelto®) significantly reduced the risk of recurrent venous thromboembolism (VTE) compared with aspirin 100 mg once daily (acetylsalicylic acid, ASA) in patients who had previously completed 6 to 12 months of anticoagulation therapy for pulmonary embolism (PE) or symptomatic deep vein thrombosis (DVT). (Source: World Pharma News)
Source: World Pharma News - March 23, 2017 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news

Physician adherence to clinical decision tools suggests potential benefit to PE patients
(American Roentgen Ray Society) A review paper published in the American Journal of Roentgenology (AJR) suggests a potential benefit to the use of clinical decision tools in the diagnostic work-up of suspected pulmonary embolism (PE) patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 23, 2017 Category: Global & Universal Source Type: news

Long-term limitations imposed on patients with pulmonary embolism
Nearly half of the patients who suffer a pulmonary embolism (PE) -- a blood clot in the lung -- experience long term limitations to their capacity for physical activity and that this had a negative impact on their quality of life, a multi-centre clinical study has determined. This research is the first to demonstrate that PE may have a lasting effect on patients. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 20, 2017 Category: Science Source Type: news

Long-term limitations imposed on patients with pulmonary embolism
(McGill University) A multi-centre clinical study, led by Dr. Susan Kahn at the Jewish General Hospital (JGH), determined that nearly half of the patients who suffer a pulmonary embolism (PE) -- a blood clot in the lung -- experience long term limitations to their capacity for physical activity and that this had a negative impact on their quality of life. This research, published in Chest, is the first to demonstrate that PE may have a lasting effect on patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 20, 2017 Category: Global & Universal Source Type: news

High-risk pulmonary embolism patients often go without most effective treatments
Researchers have found that the utilization rates of these potentially life-saving medications are low, particularly in the sub-group of PE patients who are critically ill. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 18, 2017 Category: Science Source Type: news

High-risk pulmonary embolism patients often go without most effective treatments
(University of Pennsylvania School of Medicine) In a new study presented today at the American College of Cardiology 66th Annual Scientific Session, researchers from the Perelman School of Medicine at the University of Pennsylvania have found that the utilization rates of these potentially life-saving medications are low, particularly in the sub-group of PE patients who are critically ill. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 18, 2017 Category: Global & Universal Source Type: news

Scoring Systems in the Approach to Suspected Acute PE Scoring Systems in the Approach to Suspected Acute PE
The utilization of clinical prediction rules can help drive diagnostic and therapeutic strategy decision-making in pulmonary embolism.Seminars in Respiratory and Critical Care Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 10, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Adherence to Clinical Decision Support Ups Odds of Acute PE ID
Adherence to clinical decision support linked to odds of acute pulmonary embolism finding in ER (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 27, 2017 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Emergency Medicine, Nursing, Oncology, Pulmonology, Radiology, Journal, Source Type: news

Possible Failure of NOACs in Management of Pulmonary Embolism Possible Failure of NOACs in Management of Pulmonary Embolism
Novel oral anticoagulants are fast becoming the drugs of choice when treating pulmonary embolism, but are they always as effective as warfarin?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 24, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Double trouble? Study probes link between common clotting conditions
Medical disorders related to blood clots are major contributors to disease and death worldwide. Two such disorders — atrial fibrillation and pulmonary embolism — may commonly occur in the same patients. To study this association, a team of investigators, led by Dr. Behnood Bikdeli, conducted a systematic review of the medical literature. (Source: Yale Science and Health News)
Source: Yale Science and Health News - February 14, 2017 Category: Universities & Medical Training Tags: Yale News Source Type: news

Ultrasound elevates diagnosis of pulmonary embolism
Adding lung and venous ultrasound into the diagnostic process for pulmonary...Read more on AuntMinnie.comRelated Reading: Triple rule-out CT offers one-stop shop for chest pain Can ultrasound for deep vein thrombosis cause a PE? ACP: Routine CT for suspected PE is unnecessary Feedback helps docs adhere to CT imaging guidelines Study finds growing use of emergency imaging may be justified (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 8, 2017 Category: Radiology Source Type: news

Doctors use lung ultrasound to diagnose hidden disorders
Amy WallaceJan. 31 (UPI) -- Researchers have discovered that lung ultrasound is a better diagnostic test for early diagnosis of pulmonary embolism and other disorders than current tests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 31, 2017 Category: Consumer Health News Source Type: news